Lipid Composition for APGG-201 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.975 | 0.78 | 65 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.16 mg/vial | 100 |
Lipid Composition for APGG-202 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.900 | 0.72 | 60 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.075 | 0.06 | 5 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.16 mg/vial | 100 |
Lipid Composition for APGG-203 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.900 | 0.72 | 50 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.075 | 0.06 | 15 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.16 mg/vial | 100 |
Lipid Composition for APGG-204 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.600 | 0.48 | 40 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.375 | 0.29 | 25 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-205 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.450 | 0.36 | 30 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.525 | 0.41 | 35 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-206 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.300 | 0.24 | 20 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.675 | 0.53 | 45 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-207 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.150 | 0.12 | 10 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.825 | 0.65 | 55 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-208 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.075 | 0.06 | 5 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.900 | 0.71 | 60 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-209 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.0375 | 0.03 | 2.5 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.9375 | 0.74 | 62.5 |
Cholesterol | 0.4500 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.0750 | 0.21 | 5 |
Total | 1.5000 µmol/vial | 1.15 mg/vial | 100 |
Lipid Composition for APGG-210 | Amount (µmol/vial) | Amount (mg/vial) | Molar Ratio Percentage |
---|---|---|---|
1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) | 0.015 | 0.01 | 1 |
1,2-dioleoyl-sn-glycero-3-phosphocholine | 0.960 | 0.75 | 64 |
Cholesterol | 0.450 | 0.17 | 30 |
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethyleneglycol)- 2000] (ammonium salt) | 0.075 | 0.21 | 5 |
Total | 1.500 µmol/vial | 1.15 mg/vial | 100 |